Cyclin D1, EMS1 and 11q13 amplification in breast cancer

被引:203
作者
Ormandy, CJ [1 ]
Musgrove, EA [1 ]
Hui, R [1 ]
Daly, RJ [1 ]
Sutherland, RL [1 ]
机构
[1] St Vincents Hosp, Cancer Res Program, Garvan Inst Med Res, Sydney, NSW 2010, Australia
基金
英国医学研究理事会;
关键词
breast cancer; cortactin/EMS1; cyclin D1; oncogenes; prognostic markers; 11q13; amplification;
D O I
10.1023/A:1023033708204
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chromosome locus 11q13 is frequently amplified in a number of human cancers including carcinoma of the breast where up to 15% carry this chromosomal abnormality. Originally 11q13 amplification was thought to involve a single amplicon spanning many megabases, but more recent data have identified four core regions within 11q13 that can be amplified independently or together in different combinations. Although the region harbors several genes with known or suspected oncogenic potential, the complex structure of the amplicons and the fact that 11q13 is gene-rich have made definitive identification of specific genes that contribute to the genesis and progression of breast cancer a difficult and continuing process. To date CCND1, encoding the cell cycle regulatory gene cyclin D1, and EMS1, encoding the filamentous actin binding protein and c-Src substrate cortactin, are the favored candidates responsible for the emergence of two of the four amplification cores.
引用
收藏
页码:323 / 335
页数:13
相关论文
共 84 条
[1]   Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinase [J].
Adam, L ;
Vadlamudi, R ;
Kondapaka, SB ;
Chernoff, J ;
Mendelsohn, J ;
Kumar, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (43) :28238-28246
[2]  
Alle KM, 1998, CLIN CANCER RES, V4, P847
[3]   CYCLIN D1 PROTEIN EXPRESSION AND FUNCTION IN HUMAN BREAST-CANCER [J].
BARTKOVA, J ;
LUKAS, J ;
MULLER, H ;
LUTZHOFT, D ;
STRAUSS, M ;
BARTEK, J .
INTERNATIONAL JOURNAL OF CANCER, 1994, 57 (03) :353-361
[4]  
Bautista S, 1998, GENE CHROMOSOME CANC, V22, P268, DOI 10.1002/(SICI)1098-2264(199808)22:4<268::AID-GCC2>3.3.CO
[5]  
2-U
[6]   Detailed map of a region commonly amplified at 11q13→q14 in human breast carcinoma [J].
Bekri, S ;
Adélaïde, J ;
Merscher, S ;
Grosgeorge, J ;
Caroli-Bosc, F ;
Perucca-Lostanlen, D ;
Kelley, PM ;
Pébusque, MJ ;
Theillet, C ;
Birnbaum, D ;
Gaudray, P .
CYTOGENETICS AND CELL GENETICS, 1997, 79 (1-2) :125-131
[7]   ONCOGENE AMPLIFICATION AND PROGNOSIS IN BREAST-CANCER - RELATIONSHIP WITH SYSTEMIC TREATMENT [J].
BERNS, EMJJ ;
FOEKENS, JA ;
VANSTAVEREN, IL ;
VANPUTTEN, WLJ ;
DEKONING, HYWCM ;
PORTENGEN, H ;
KLIJN, JGM .
GENE, 1995, 159 (01) :11-18
[8]   PREVALENCE OF AMPLIFICATION OF THE ONCOGENES C-MYC, HER2 NEU, AND INT-2 IN 1000 HUMAN BREAST-TUMORS - CORRELATION WITH STEROID-RECEPTORS [J].
BERNS, EMJJ ;
KLIJN, JGM ;
VANSTAVEREN, IL ;
PORTENGEN, H ;
NOORDEGRAAF, E ;
FOEKENS, JA .
EUROPEAN JOURNAL OF CANCER, 1992, 28A (2-3) :697-700
[9]   GENETIC ALTERATIONS IN BREAST-CANCER [J].
BIECHE, I ;
LIDEREAU, R .
GENES CHROMOSOMES & CANCER, 1995, 14 (04) :227-251
[10]   Cyclin D1 represses STAT3 activation through a Cdk4-independent mechanism [J].
Bienvenu, F ;
Gascan, H ;
Coqueret, O .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (20) :16840-16847